namcp Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Report: Interoperability does not affect EHR buying decision

Healthcare research firm KLAS reports that healthcare providers remain strongly concerned about interoperability of technology from various vendors and "strongly encourage better coordination among vendors, timely location of patient records and greatly improved parsing...

source: By Scott E. Rupp
Search past issues
Search products and services

As part of the pre-appointment activities before an annual physical, patients at NorthShore University HealthSystem complete an electronic risk-assessment questionnaire to determine if genomic testing for certain inherited cancers, cardiovascular...

source: Health Data Management

If ever a technology was the opposite of plug-and-play, artificial intelligence is it. Beyond the obvious table stakes – having sound information and a smart data strategy – getting AI right requires a broad array of closely interrelated technologies to work...

source: Healthcare IT News

Fifteen years ago, Humber River Hospital began its journey to become the first fully digital hospital in North America. Their commitment was to create a state-of-the-art acute care facility that put caring for patients,...

source: USA Tpdau

Researchers report that they have successfully created spinal cord neural stem cells (NSCs) from human pluripotent stem cells (hPSCs) that differentiate into a diverse population of cells capable of dispersing throughout the spinal cord...

source: University of California - San Diego via ScienceDaily

Researchers from the Stowers Institute for Medical Research and collaborators have identified a way to expand blood-forming, adult stem cells from human umbilical cord blood (hUCB). This development could make these cells available...

source: Stowers Institute for Medical Research via ScienceDaily

Proponents of precision medicine cite the growing numbers of successful precision cancer drugs. The examples of Herceptin (trastuzumab), Gleevec (imatinib mesylate), Xalkori (crizotinib), and Zelboraf (vemurafenib) come to mind. Skeptics, on the other hand, focus on the...

source: Forbes


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to Genomics Biotechnology & Emerging Medical Technologies Institute e-News

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of NAMCP? Yes   No
Privacy Policy